View source for Direct evaluation involving a couple of lengthy halflife PEGylated recombinant FVIII goods a new randomized crossover pharmacokinetic review throughout patients with severe hemophilia Any
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.